Mandate

VINGE ADVISES BAIN CAPITAL AND BRAVIDA

June 20, 2013

Vinge and Kirkland & Ellis are advising Bain Capital and Bravida in connection with the refinancing of Bravida, which includes the issue of senior secured floating rate notes in the amount of SEK 1.3 billion and EUR 225 million.

Vinge’s team consists of partners Stefan de Hevesy, Christina Kokko and Peter Bäärnhielm together with associates Robin Dangoor, Paul Dali, Charlotta Järnstedt, Andreas Malmberg, Dain Nevonen and Marie Brommesson.

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026